RITUXIMAB, LENALIDOMIDE , RITUXIMAB, RITUXIMAB, RITUXIMAB
FIL_Renoir12
Phase 3 small_molecule active
Quick answer
RITUXIMAB, LENALIDOMIDE , RITUXIMAB, RITUXIMAB, RITUXIMAB for Follicular lymphoma is a Phase 3 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Follicular lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active